He has been running his own urological surgery practice in Geneva since Greg was nice enough to grant my request for an email interview, and answered each of my questions, as you can read below. It approves the variable remuneration granted to individual members of the Corporate Executive Committee; from this remuneration has to be within the maximum amount approved by the Annual General Meeting. Denis Arsenault steps up to Executive Chairman. Jane is a member of the Remuneration and Nominations Committees.
We are confident that when the market shifts to evaluating companies on their fundamentals we will be a top performer based on our low production costs and high yields as well as our high-quality, indoor-grown product. I thank Greg Engel for his time and candor in answering my questions.
I also believe a number of clues have been unearthed as to what's next for OrganiGram, and the industry as a whole. For example, Engel's commentary on partnerships suggests that cannabis growers are just about ready to move onto the next stage of development.
With capacity expansion in full swing across the board, the next steps involve product line expansion i. Though OrganiGram may not be a top-five grower in terms of annual production at full capacity, its focus on oils and in keeping its costs down -- unlike its peers, it keeps its costs in check by operating a single grow site -- along with a strong branding strategy, could allow its margins to be superior to much of its competition.
Engel also makes a good point noting that even though expansion at Moncton won't be complete until April , by the company's own estimate, its current run rate of 36, kilograms annually is actually quite good. Remember, most growers were apprehensive about spending tens or hundreds of millions of dollars on capacity expansion until the past six or seven months, when it became apparent that the Cannabis Act would eventually become law.
As a result, project completion for all major and mid-tier growers tends to be anywhere from the second half of this year through the end of Even though OrganiGram won't reach full production capacity for close to two years, it's not necessarily at a disadvantage to its peers, which are going through a similar expansion cycle. Finally, without reading between the lines too much, it seems apparent that OrganiGram is preparing to remain an independent company.
As much as it might appear an intriguing buyout opportunity for larger growers given its impressive yields and diversified production capabilities, its geographic location could dissuade buyers. Plus, I personally believe investors have a better chance to see stronger long-term returns if OrganiGram remains an independent company.
While this industry may take time to mature, OrganiGram Holdings is a marijuana stock worth keeping a close eye on. More From The Motley Fool. Sean Williams has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Search Now you can search stock related news and private companies such as Airbnb. No matching results for ''. Try a valid symbol or a specific company name for relevant results.
From to he was Chairman of the Swiss Association of Urology. He is a member of the Swiss Association of Urology, the European Association of Urology and other professional bodies and associations. Dr Georges-Antoine de Boccard is an independent non-executive director.
Gloor , Switzerland, university degree in business economics has been a member of the Board of Directors since Gallen, since November Gloor is an independent non-executive director. Karin Keller-Sutter , Switzerland, university degree in translation and conference interpreting, postgraduate qualification in education has been a member of the Board of Directors since In she was elected to St.
Gallen before being elected to St. She has been a member of the Council of States — the upper chamber of the Swiss parliament — since the autumn of and was appointed as Chairwoman in Karin Keller-Sutter is an independent non-executive director. Hugo Lasat is an independent non-executive director. Thomas von Planta , Swiss, Dr iur.
Dr Thomas von Planta is an independent non-executive director. Thomas Pleines , Germany, lawyer has been a member of the Board of Directors since KG, Au near Freiburg. Thomas Pleines is an independent non-executive director. Professor Hans-Jörg Schmidt-Trenz is an independent non-executive director.
She is a lawyer and honorary professor at the School of Economics and Management at the University of Geneva, where she mainly lectures on corporate law. The Board of Directors has four committees, which support it in its activities. He went on to work in a variety of areas including the roles of National Advertising Manager and National Marketing Manager, before being appointed General Manager in , and then MD in Before joining Subaru, Nick was a journalist, including as a motoring writer on the Daily Mirror and Daily Telegraph newspapers in Sydney.
He also worked for Audi in the U. Registered in England and Wales with company number Who We Are Inchcape plc is the global distribution and retail leader in the premium and luxury automotive sectors.
What We Do We seek to embed trust as our highest priority at every stage of our value chain, from product planning to brand management, from car retailing to Aftersales. Our value chain Our brand partners Where we operate Awards. Careers Inchcape currently employs around 18, people based in markets across the world to give our customers, businesses and manufacturers a wide variety of automotive services — from distribution to retail, aftersales and financial services.
Why Inchcape Careers contacts. Nigel succeeded Ken Hanna as Chairman in May Stefan Bomhard Group Chief Executive. Richard Howes Chief Financial Officer. Jerry Buhlmann Non-Executive Director. Rachel Empey Non-Executive Director.
Rachel is a member of the Audit and Nominations Committees. John Langston Non-Executive Director. Nigel Northridge Senior Independent Director.